Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, overview | Mus musculus | |
additional information | ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, overview | Rattus norvegicus | |
additional information | ODC induction, e.g. in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate, is a necessary step in MEK-induced tumorigenesis, overview, ODC is induced during carcinogenesis by a variety of oncogenic stimuli, ODC activity is induced in cells that overexpress the translation initiation factor eIF4E, overview | Homo sapiens |
Application | Comment | Organism |
---|---|---|
diagnostics | a single nucleotide polymorphism in intron 1 of the ODC gene serves as genetic marker for colon cancer | Homo sapiens |
drug development | the enzyme ODC is a drug target in human malignancies, such as skin cancer | Homo sapiens |
pharmacology | the enzyme ODC is possibly useful in chemotherapy of human malignancies, such as skin cancer | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression of ODC in transgenic mice or rats leading to altered, tumoric skin phenotypes, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc, expression in NIH-3T3 cells overexpressing eIF4E, alpha-difluoromethylornithine not only inhibits proliferation, but also reverts the transformed phenotype of NIH-3T3 cells overexpressing eIF4E | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | ODC transgenic rodent models of skin carcinogenesis, phenotypes, overview | Homo sapiens |
additional information | transgenic mice overexpressing ODC in hair follicle keratinocytes using keratin promotors are much more sensitive than littermate controls to DMBA-induced carcinogenesis, and do not require treatment with a tumor promoter to develop tumors, overview | Mus musculus |
General Stability | Organism |
---|---|
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Mus musculus |
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Homo sapiens |
the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
alpha-difluoromethylornithine | i.e. DFMO, irreversible inactivator, physiologic effects, e.g. causes arrest in G1 phase in neuroblastoma cells, the cytostatic effect is reversible by putrescine, overview, acts synergistically with SAM486A, MDL-73811, cisplatin, and 5-fluorouracil | Homo sapiens | |
alpha-difluoromethylornithine | i.e. DFMO, irreversible inactivator, antitumor action of ODC inhibition using DFMO, chemopreventive effects, DFMO provides significant protection against N-butyl-N(4-hydroxybutyl)-nitrosamine-induced bladder cancer, overview | Mus musculus | |
alpha-difluoromethylornithine | i.e. DFMO, irreversible inactivator, antitumor action of ODC inhibition using DFMO, chemopreventive effects, DFMO provides significant protection against 7,12-dimethylbenz[a]-anthracene-induced mammary carcinogenesis, overview | Rattus norvegicus | |
antizyme | an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Homo sapiens | |
antizyme | an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Mus musculus | |
antizyme | an important endogenous regulator of ODC and polyamine homeostasis, overview, the wild type form of ODC has an extremely short half life of 20-30 min, and its degradation is mediated by antizyme, which binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Rattus norvegicus | |
additional information | the enzyme is induced by phorbol esters, rapamycin, which blocks phosphorylation of 4E-BP1, inhibits the induction of ODC in response to serum | Homo sapiens | |
additional information | inhibition of ODC activity reverts the transformation of cells in vitro and reduces tumor growth | Mus musculus | |
additional information | inhibition of ODC activity reverts the transformation of cells in vitro and reduces tumor growth | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-ornithine | Rattus norvegicus | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview | putrescine + CO2 | - |
? | |
L-ornithine | Homo sapiens | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms, e.g. via the Ras effector pathways, and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects, overview | putrescine + CO2 | - |
? | |
L-ornithine | Mus musculus | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview | putrescine + CO2 | - |
? | |
additional information | Mus musculus | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview | ? | - |
? | |
additional information | Rattus norvegicus | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview | ? | - |
? | |
additional information | Homo sapiens | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, the Raf/MEK/ERK cascade mediates ODC transcription and the PI 3-kinase cascade mediates ODC translation, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
MEK mutant K14-MEK mice | - |
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
AR4-2J cell | AR4-2J pancreatic tumor cells, which show increased phosphorylation of the eIF4E regulatory protein 4E-BP1 and high levels of eIF4E compared to normal cells, also exhibit increased translational initiation of ODC mRNA | Rattus norvegicus | - |
B-16 cell | melanoma cell line | Mus musculus | - |
COLO-357 cell | - |
Homo sapiens | - |
hepatoma cell | - |
Homo sapiens | - |
hepatoma cell | - |
Rattus norvegicus | - |
IEC-6 cell | intestinal epithelial cells | Rattus norvegicus | - |
intestine | - |
Rattus norvegicus | - |
L-1210 cell | leukemia cell line | Mus musculus | - |
LAN-1 cell | neuroblastoma cell line | Homo sapiens | - |
Lewis lung carcinoma cell | - |
Mus musculus | - |
melanoma cell | - |
Homo sapiens | - |
neuroblastoma cell | - |
Homo sapiens | - |
NMB-7 cell | neuroblastoma cell line | Homo sapiens | - |
PANC-1 cell | - |
Homo sapiens | - |
pancreas | - |
Homo sapiens | - |
pancreatic cancer cell | - |
Homo sapiens | - |
renal cell carcinoma cell | - |
Homo sapiens | - |
skin | - |
Mus musculus | - |
skin | - |
Homo sapiens | - |
skin | - |
Rattus norvegicus | - |
small cell lung carcinoma cell | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-ornithine | - |
Mus musculus | putrescine + CO2 | - |
? | |
L-ornithine | - |
Homo sapiens | putrescine + CO2 | - |
? | |
L-ornithine | - |
Rattus norvegicus | putrescine + CO2 | - |
? | |
L-ornithine | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview | Rattus norvegicus | putrescine + CO2 | - |
? | |
L-ornithine | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation regulation occurs at the levels of transcription, translation and protein degradation, mechanisms, e.g. via the Ras effector pathways, and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects, overview | Homo sapiens | putrescine + CO2 | - |
? | |
L-ornithine | first enzyme in polyamine biosynthesis, the unique and tight regulation of the enzyme occurs at the levels of transcription, translation and protein degradation, dysregulation of ornithine decarboxylase during oncogenic transformation, mechanisms and therapeutic potential, overview, ODC induction as a necessary step in MEK-induced tumorigenesis, enzyme inhibition reduces tumor growth, synergistic or additive effects with vindesine or doxorubicin, overview | Mus musculus | putrescine + CO2 | - |
? | |
additional information | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview | Mus musculus | ? | - |
? | |
additional information | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, overview | Rattus norvegicus | ? | - |
? | |
additional information | the Raf/MEK/ERK pathway is involved in the regulation of ODC during skin tumorigenesis, the Raf/MEK/ERK cascade mediates ODC transcription and the PI 3-kinase cascade mediates ODC translation, overview, a single nucleotide polymorphism occurs in intron 1 of the ODC gene, which results in increased ODC expression in response to Myc | Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Mus musculus |
dimer | antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Homo sapiens |
dimer | antizyme binds to the monomeric form of ODC, preventing formation of the enzymatically active homodimer, and then targets ODC for degradation | Rattus norvegicus |
Synonyms | Comment | Organism |
---|---|---|
ODC | - |
Mus musculus |
ODC | - |
Homo sapiens |
ODC | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
pyridoxal 5'-phosphate | - |
Mus musculus | |
pyridoxal 5'-phosphate | - |
Homo sapiens | |
pyridoxal 5'-phosphate | - |
Rattus norvegicus |